title: Developing a structure-function relationship for anionic porphyrazines exhibiting selective anti-tumor activity.
abstract: The porphyrazines (pzs) are a class of porphyrin derivatives being studied for their use as optical imaging agents and photodynamic therapy (PDT) anti-tumor agents. A previous study revealed that the anionic pz, 18--of the form H2[pz(An;B4-n)], where A is [S(CH2)3CO2-], B is a fused beta',beta'-diisopropyloxy benzo group, with n=2 (trans)--selectively killed tumor cells, while analogous neutral and positively charged pzs lacked this property. In this report, we compare the properties of a suite of three H2[pz(An;B4-n)] pzs containing the same A and B groups as 18, but differing in their values of n: pzs 4 (n=4) and 11 (n=3), and 18 (n=2, trans) exhibit a progressive variation in charge due to the carboxylates, balance between hydrophobic/hydrophilic character, as well as a progressive variation in the singlet oxygen quantum yield (PhiDelta): PhiDelta (18)>PhiDelta (11)>PhiDelta (4). The biological activity of the pzs was tested in human lung carcinoma (A549) and SV40 transformed embryonic (WI-38 VA13) cell lines. Pzs 4 and 11 exhibited significant toxicity in both tumor and normal cells, while 18 showed selective anti-tumor cell activity in a dose-dependent manner. As the number of net negative charges decreased, the compounds became less toxic to normal cells, and the killing effect observed with these compounds was light independent. These observations indicate that the toxicity may have little to do with singlet oxygen quantum yields, but rather is more dependent on the net number of negative charges a pz contains. The study reported herein presents an example of how the porphyrazines can be easily modified to vary their biological behavior and specifically suggest that anionic porphyrazines pzs with lower n (fewer carboxylates, larger hydrophobic core) are more specific tumor killers, while those with larger n (increased net negative charge) are more potent tumor killers.
authors.affiliation: Center for Molecular Biology of Oral Diseases, University of Illinois - Chicago, College of Dentistry, 801 S. Paulina, Chicago, IL 60612, USA. vesperbe@uic.edu
authors.forename: Benjamin J
authors.initials: BJ
authors.lastname: Vesper
authors.forename: Sangwan
authors.initials: S
authors.lastname: Lee
authors.forename: Neal D
authors.initials: ND
authors.lastname: Hammer
authors.forename: Kim M
authors.initials: KM
authors.lastname: Elseth
authors.forename: Anthony G M
authors.initials: AG
authors.lastname: Barrett
authors.forename: Brian M
authors.initials: BM
authors.lastname: Hoffman
authors.forename: James A
authors.initials: JA
authors.lastname: Radosevich
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D006801:Humans; D017319:Photosensitizing Agents / Q000494:pharmacology*; D011166:Porphyrins / Q000737:chemistry / Q000494:pharmacology*; D013050:Spectrometry, Fluorescence; D019265:Spectroscopy, Near-Infrared; D013329:Structure-Activity Relationship
chemical_list: D000970:Antineoplastic Agents; D017319:Photosensitizing Agents; D011166:Porphyrins